REG - JPMorgan Chase & Co - Form 8-K October 14, 2025 (3Q2025 presentation)

RNS Number : 3491D JPMorgan Chase & Co 14 October 2025 Regulatory AnnouncementJPMorgan Chase & Co.October 14, 2025JPMorgan Chase & Co. has submitted the following document for posting on the website of Euronext Dublin and to the National Storage Mechanism of the UK Financial Conduct Authority:• Current Report on Form 8-K of JPMorgan Chase & Co. dated October 14, 2025 containing the slides furnished for an investor presentation held on October 14, 2025 to review JPMorgan Chase & Co.'s 2025 third quarter earnings, as furnished to the U.S. Securities and Exchange Commission.This document may also be viewed on the U.S. Securities and Exchange Commission's website (www.sec.gov) and on JPMorgan Chase & Co.'s investor relations website (https://jpmorganchaseco.gcs-web.com/ir/sec-other-filings/overview).For further information, please contact:Reid R. BrodaCorporate SecretaryJPMorgan Chase & Co.Telephone number: +001 212 270 6000Fax number: +001 212 270 4240Email: reid.r.broda@jpmchase.comDISCLAIMER — INTENDED ADDRESSEESPlease note that the information contained in the above mentioned document(s) may be addressed to and/or targeted at persons who are residents of particular countries (specified in such document(s)) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom such document(s) is not addressed. Prior to relying on the information contained in such document(s) you must ascertain from the document(s) whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DOCBSBDGUDBDGUS